Markel Group Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 4/6
Markel Group verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 9.2%, während die Gewinne der Branche Insurance jährlich um gewachsen und zwar um 14.7%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 7.8%. Die Eigenkapitalrendite von Markel Group beträgt 12% und die Nettomargen betragen 13.8%.
Wichtige Informationen
9.20%
Wachstumsrate der Gewinne
11.35%
EPS-Wachstumsrate
| Insurance Wachstum der Industrie | 8.02% |
| Wachstumsrate der Einnahmen | 7.79% |
| Eigenkapitalrendite | 11.95% |
| Netto-Marge | 13.75% |
| Letzte Ertragsaktualisierung | 30 Jun 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Seeking Alpha • Aug 07
Markel: Insurance Book Issues Re-Surface, But Value Remains Compelling
Summary Markel remains resilient despite Q2 volatility, with strong insurance and consumer segments offsetting financial division setbacks. MKL trades near 20-year lows on price-to-book, appearing historically cheap given robust investment income and tangible book growth. Net investment income surged 11% in H1 FY2026, now comprising roughly half of adjusted earnings; tangible book value per share grew 13-14% over five years. With a 14% return on tangible equity and potential for valuation re-rating, MKL offers a compelling 20%+ medium-term annual return potential despite insurance book risks. Read the full article on Seeking Alpha
Narrative-Update • Jul 01
MKL: Acquisitions And Activist Pressure Will Test Fairly Valued Specialty Focus
Analysts have trimmed their price target for Markel Group to approximately $1,955 from about $2,005, citing updated fair value estimates and slightly lower assumed future P/E multiples in their models. What’s in the News for Markel Group Markel Group continues to use acquisitions as a core part of its capital allocation approach, with recent deals aimed at expanding specialty insurance capabilities and diversifying earnings, according to recent coverage.Narrative-Update • Jun 17
MKL: AI And Specialty Focus Will Meet Activist And Execution Tests
Analysts have lowered their price target on Markel Group stock by $150, citing updated views reflected in recent Neutral ratings and target revisions. They have left key long term valuation inputs essentially unchanged, including fair value, discount rate, revenue growth, profit margin, and future P/E.Narrative-Update • Jun 02
MKL: AI And Specialty Focus Will Drive Upside Despite Governance Pressure
Analysts have trimmed their price target on Markel Group by $150, pointing to recent research that reflects a more neutral stance on the stock while largely reaffirming key valuation inputs. Analyst Commentary Recent research on Markel Group reflects a more neutral stance, with the trimmed price target largely reflecting updated assumptions rather than a wholesale change in thesis.Narrative-Update • May 15
MKL: Neutral Outlook Will Balance Governance Pressure With Ongoing Share Repurchases
Analysts have trimmed their price target on Markel Group by about $64 to $2,005. This reflects updated assumptions around higher discount rates, a different revenue growth outlook, a slightly lower profit margin, and a modestly adjusted future P/E.Narrative-Update • Apr 28
MKL: Future Outlook Will Weigh Neutral Rating Governance Changes And Ongoing Buybacks
Analysts have adjusted their price target on Markel Group to $2,069, reflecting updated views on fair value, discount rate, and long term profit assumptions following recent research, including a resumed Neutral rating at Brean Capital and a $100 price target revision at Truist. Analyst Commentary Bullish Takeaways Bullish analysts view the updated US$2,069 price target and recent US$100 upward revision as better aligned with their view of Markel Group's fair value, given current assumptions on profitability and risk.Narrative-Update • Apr 13
MKL: Future Outlook Will Weigh Buybacks Neutral Stance And Steady Earnings
Analysts have trimmed their Markel Group price target by about $16 to reflect slightly updated assumptions around fair value, revenue growth, profit margin and future P/E, following recent research that includes a resumed Neutral rating and a separate $100 price target adjustment. Analyst Commentary Recent Street research on Markel Group highlights a mix of optimism and caution, with one set of analysts resuming coverage at Neutral and another adjusting the price target by about $100 based on updated assumptions.Narrative-Update • Mar 29
MKL: Future Outlook Will Reflect Buybacks And Stable Earnings Expectations
Analysts have nudged their fair value target for Markel Group up by about $14 to $2,085, citing updated expectations around revenue growth, profit margins, a slightly lower future P/E multiple, and recent Street research that includes a resumed Neutral rating and a $100 price target adjustment. Analyst Commentary Bullish Takeaways Bullish analysts view the resumed Neutral coverage as a sign that Markel Group remains investable, with fundamentals viewed as sufficiently stable to support updated fair value work.Narrative-Update • Mar 11
MKL: Future Outlook Will Reflect Buybacks And Stable Earnings Assumptions
Analysts have increased their price target on Markel Group by $100, citing updated assumptions around revenue growth, profit margins, and future P/E, which they say support a fair value estimate of $2,071.75. Analyst Commentary Analysts updating their models around Markel Group are framing the new $2,071.75 fair value estimate in terms of how realistic the revised revenue, margin, and P/E assumptions look over time.Narrative-Update • Feb 22
MKL: Future Outlook Will Reflect Buybacks And Refined Earnings Assumptions
Analysts have lifted their price target on Markel Group by $100 to $2,071.75, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a slightly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts argue that the refreshed fair value work supports the higher price target, with updated assumptions across revenue, margins and P/E bringing their framework closer to current market conditions.Narrative-Update • Feb 08
MKL: Future Outlook Will Reflect Buybacks And Steady Earnings Assumptions
Analysts have nudged their fair value estimate for Markel Group higher from US$2,041.40 to US$2,064.25, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples reflected in recent Street research. Analyst Commentary Bullish Takeaways Bullish analysts view the higher fair value estimate of US$2,064.25 as consistent with refreshed assumptions on revenue growth and profit margins.Narrative-Update • Jan 25
MKL: Future Outlook Will Reflect Completed Buybacks And Stable Earnings Assumptions
Analysts now see fair value for Markel Group at about $2,041 per share, roughly $10 lower than before. This reflects slightly different views on revenue growth, profit margins and the forward P/E that feed into their updated price target work.Narrative-Update • Jan 10
MKL: Future Outlook Will Reflect Steady Buybacks And Stable Earnings Assumptions
Analysts have maintained their fair value estimate for Markel Group at about $2,051, with only very small tweaks to the discount rate, long term revenue growth, profit margin, and future P/E assumptions. This reflects largely unchanged views on the stock’s risk and earnings power.Narrative-Update • Dec 24
MKL: Future Outlook Will Reflect Buybacks And 2025–2026 Earnings Estimates
Analysts have modestly lifted their price target on Markel Group, with updated models incorporating 2025 and 2026 estimates supporting a move from approximately $2,051 to about $2,107 per share. Analyst Commentary Analysts characterize the latest target increase as a valuation catch up to improved earnings visibility rather than a shift to a more constructive stance on the stock.Narrative-Update • Dec 10
MKL: Medium-Term Outlook Will Reflect Buybacks And 2025–2026 Earnings Visibility
Analysts have modestly lifted their price target on Markel Group, raising it by approximately $270 to around $2,100 per share. Updated 2025 and 2026 estimates support a slightly higher valuation outlook.Narrative-Update • Nov 26
MKL: Medium-Term Performance Will Reflect Buybacks and Revised 2025 Outlook Updates
Narrative Update on Markel Group Analysts have increased their fair value estimate for Markel Group by $40, citing stronger revenue growth forecasts and recent model updates for 2025 and 2026. Analyst Commentary Bullish Takeaways Bullish analysts point to updated forecasts that show robust revenue growth through 2025 and 2026, emphasizing the company’s expanding market reach.Narrative-Update • Nov 05
MKL: Future Revenue Expectations And Buybacks Will Shape Medium-Term Performance
Analysts have increased their price target for Markel Group from $1,836 to $2,107, citing stronger expected revenue growth as well as updated forecasts for 2025 and 2026. Analyst Commentary Recent analyst discussions have centered on Markel Group's updated financial outlook and the implications for its valuation.Narrative-Update • Oct 22
Analysts Lift Markel Group Price Target Amid Confident Outlook and Ongoing Share Buybacks
Analysts have raised their price target for Markel Group from $1,985.40 to $2,009.40, citing updated models with new revenue growth and profit margin estimates for the coming years. Analyst Commentary Bullish Takeaways Bullish analysts have increased price targets in response to stronger revenue growth and improved profit margin projections in updated financial models.Narrative-Update • Oct 08
Decentralized Operations And Digital Transformation Will Improve Specialty Insurance Outcomes
Narrative Update on Markel Group Analysts have increased their fair value estimate for Markel Group from $1,931.20 to $1,985.40. This change reflects updates to forward assumptions and continued model revisions that account for revised future estimates.Narrative-Update • Sep 04
Decentralized Operations And Digital Transformation Will Improve Specialty Insurance Outcomes
As both consensus revenue growth and net profit margin forecasts for Markel Group remain steady, analysts have left their price target unchanged at $1931. What's in the News Repurchased 49,140 shares (0.39%) for $90.45 million in Q2 2025, completing repurchase of 194,494 shares (1.52%) for $351.23 million under the current buyback program.Seeking Alpha • Mar 20
Markel Group: Positive Change In Insurance Leadership
Summary I view the appointment of Simon Wilson as CEO of Markel Insurance as highly positive. Share buybacks will keep increasing due to the option to redeem the preferred shares at $1,000 per share on June 1st. The value of the insurance business and Markel Ventures separately exceeds its current market cap, but a spin-off would not be positive over the long term. The long-term debt is rolled over at higher rates, increasing Markel's investment income. Read the full article on Seeking AlphaSeeking Alpha • Jan 28
Markel: Why You Should Consider Buying This Stock In 2025
Summary I rate Markel as a 'buy' due to its strong business model combining insurance, investments, and ventures, similar to Berkshire Hathaway. Markel stands out as a well-diversified insurance company with a robust business model. The company benefits from exceptional management, driving consistent performance and growth. Its long-term strategic focus positions it for sustained success in the insurance industry. Read the full article on Seeking AlphaSeeking Alpha • Dec 30
Markel: Still A Hold
Summary Despite strong recent performance, I maintain a "Hold" rating on Markel due to potential challenges in both its insurance and investment segments. Markel's Q3/24 results were exceptional, with a 36.6% YoY revenue increase and a significant jump in operating income and EPS. The investment business showed substantial gains, but fluctuating investment results make metrics like P/E ratio less reliable for valuation. Despite low valuation multiples, I remain cautious about financial businesses like Markel facing potential headwinds in the coming years. Read the full article on Seeking AlphaSeeking Alpha • Oct 14
Markel Stock: High-Quality At A Discount
Summary Markel stock trades at a significant discount to peers, despite strong investment income and improved underwriting, making it an attractive entry point for investors. The company’s investment portfolio, worth ~$30 billion, and Markel Ventures, valued at $6 billion, provide a substantial margin of safety. Markel has compounded book value at 11% annually and is expected to continue growing at low double-digit rates, despite earnings volatility. Investors with a long-term horizon should consider Markel for its low-risk growth potential and attractive risk-return tradeoff. Read the full article on Seeking AlphaSeeking Alpha • Sep 25
Markel: Remains A Long Term Buy
Summary Markel has a strong 30+ year track record but faced recent growth challenges due to natural catastrophes, economic inflation, and poor acquisitions. Despite setbacks, Markel's integrity and strategic actions have led to improving fundamentals, with book value growing annually and a promising future outlook. Growth re-acceleration is expected through insurance premium growth, profitability improvements, Ventures acquisitions, and sustained high-interest income from the insurance float. Risks include longer tail insurance losses and executive turnover, but strong leadership and strategic measures mitigate these concerns, making Markel a long-term attractive stock. Read the full article on Seeking AlphaSeeking Alpha • Aug 22
Markel Group's Q2: Nearly A Century Of Growth Facing Modern Headwinds
Summary Markel Group Inc., a diversified holding company, operates in insurance, investments, and Markel Ventures. Recent financial performance has been lackluster, with lower-than-expected earnings and revenue. Despite solid long-term growth, Markel faces challenges such as underperformance in EBITDA and cash flow, leading to a “Hold” rating. Read the full article on Seeking AlphaSeeking Alpha • Jun 02
Markel Group: Higher-For-Longer Interest Rates Are Increasing Profitability
Summary Markel Group stock is up 15.6% in 2024, on track to meet the projected 24% increase for the full year. The Q1 results show positive performance in insurance, investments, and Markel Ventures. Markel accelerated its share buyback program, nearly doubling its purchases to $161 million and reducing the share count by 2.3% year-over-year. As interest rates remain high, Markel's float becomes more valuable, benefiting from increased yields. Despite the recent price increase, I still consider Markel's shares to be undervalued. Read the full article on Seeking AlphaAufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Markel Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 26 | 16,596 | 2,282 | 0 | 0 |
| 31 Mar 26 | 16,013 | 1,746 | 0 | 0 |
| 31 Dec 25 | 16,589 | 2,140 | 0 | 0 |
| 30 Sep 25 | 16,210 | 1,882 | 0 | 0 |
| 30 Jun 25 | 16,454 | 2,073 | 0 | 0 |
| 31 Mar 25 | 15,553 | 1,762 | 0 | 0 |
| 31 Dec 24 | 16,621 | 2,599 | 0 | 0 |
| 30 Sep 24 | 17,422 | 3,012 | 0 | 0 |
| 30 Jun 24 | 16,186 | 2,106 | 0 | 0 |
| 31 Mar 24 | 16,627 | 2,457 | 0 | 0 |
| 31 Dec 23 | 15,804 | 1,966 | 0 | 0 |
| 30 Sep 23 | 15,372 | 1,882 | 0 | 0 |
| 30 Jun 23 | 15,063 | 1,882 | 0 | 0 |
| 31 Mar 23 | 12,712 | 269 | 0 | 0 |
| 31 Dec 22 | 11,675 | -322 | 0 | 0 |
| 30 Sep 22 | 11,223 | -130 | 0 | 0 |
| 30 Jun 22 | 10,844 | 36 | 0 | 0 |
| 31 Mar 22 | 12,552 | 1,766 | 0 | 0 |
| 31 Dec 21 | 12,846 | 2,434 | 0 | 0 |
| 30 Sep 21 | 12,444 | 2,398 | 0 | 0 |
| 30 Jun 21 | 12,668 | 2,619 | 0 | 0 |
| 31 Mar 21 | 12,300 | 2,740 | 0 | 0 |
| 31 Dec 20 | 9,735 | 769 | 0 | 0 |
| 30 Sep 20 | 8,961 | 451 | 0 | 0 |
| 30 Jun 20 | 8,082 | 215 | 0 | 0 |
| 31 Mar 20 | 7,389 | -193 | 0 | 0 |
| 31 Dec 19 | 9,526 | 1,792 | 0 | 0 |
| 30 Sep 19 | 7,988 | 539 | 0 | 0 |
| 30 Jun 19 | 8,190 | 743 | 0 | 0 |
| 31 Mar 19 | 7,738 | 521 | 0 | 0 |
| 31 Dec 18 | 6,841 | -133 | 0 | 0 |
| 30 Sep 18 | 7,461 | 1,041 | 0 | 0 |
| 30 Jun 18 | 6,731 | 382 | 0 | 0 |
| 31 Mar 18 | 6,225 | 248 | 0 | 0 |
| 31 Dec 17 | 6,062 | 362 | 0 | 0 |
| 30 Sep 17 | 5,828 | 65 | 0 | 0 |
| 30 Jun 17 | 5,753 | 406 | 0 | 0 |
| 31 Mar 17 | 5,648 | 338 | 0 | 0 |
| 31 Dec 16 | 5,612 | 440 | 0 | 0 |
| 30 Sep 16 | 5,604 | 511 | 0 | 0 |
| 30 Jun 16 | 5,515 | 536 | 0 | 0 |
| 31 Mar 16 | 5,444 | 554 | 0 | 0 |
| 31 Dec 15 | 5,370 | 587 | 0 | 0 |
| 30 Sep 15 | 5,285 | 501 | 0 | 0 |
Qualität der Erträge: MKL hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: MKLDie aktuellen Gewinnspannen (13.8%) sind höher als im letzten Jahr (12.6%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: MKLIn den letzten 5 Jahren sind die Gewinne von 9.2% jährlich gestiegen.
Beschleunigtes Wachstum: MKLDas Gewinnwachstum des Unternehmens im letzten Jahr (10.1%) übertrifft seinen 5-Jahres-Durchschnitt (9.2% pro Jahr).
Erträge im Vergleich zur Industrie: MKL Das Gewinnwachstum im vergangenen Jahr (10.1%) übertraf nicht die Entwicklung der Branche Insurance 27.4% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: MKLDie Eigenkapitalrendite des Unternehmens (12%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/09/09 18:02 |
| Aktienkurs zum Tagesende | 2026/09/09 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Markel Group Inc. wird von 16 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Cohen | BofA Global Research |
| Robert Farnam | Brean Capital Historical (Janney Montgomery) |